TransMedics Group (TMDX) Price to Earnings Ratio

How do the influx of bioengineers and the ambitious mission of TransMedics Group (TMDX) impact its market capitalization? The P/E valuation profile of TransMedics Group (TMDX) on GURU.Markets provides the answer, with the latest reading standing at 22.60. Business growth relies on partnerships with transplant centers to establish organ logistics, while the environmental strategy is limited to plastic recycling and energy saving in offices.

For TransMedics Group (TMDX), a leader in the organ perfusion systems segment, market value is determined by the balance between current capital and actual profits from the sale of medical devices and logistics. By analyzing the company's fundamental P/E ratio, an investor compares total market capitalization with annual net income, which allows for the identification of asset overvaluation or the discovery of an entry point during business undervaluation.